Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The investigators are doing this study to look at how different doses of the Depot
medroxyprogesterone acetate (DMPA) shot effect weight gain and bone mineral density in teens.
The investigators hope that what the investigators learn from this study will be used to
develop ways to keep girls from gaining weight or losing bone density when receiving DMPA.